Table 3.

Association between autotaxin and cardiometabolic risk factors at 6 months

	All		Men		Women
Number of participants	69		20		49
	r	P	r	P	r	P
Age	−0.10	0.42	−0.04	0.86	0.01	0.95
Body weight	−0.12	0.33	0.37	0.12	0.13	0.38
BMI	0.17	0.17	0.19	0.44	0.19	0.21
Fat percent	0.40	0.0009	0.21	0.38	0.03	0.85
Fat mass	0.20	0.12	0.26	0.29	0.09	0.56
Fat‐free mass	−0.31	0.01	0.18	0.47	0.21	0.16
Apo B	0.17	0.18	−0.09	0.71	0.25	0.09
LDL‐C	0.10	0.43	0.18	0.46	0.05	0.74
HDL‐C	0.10	0.47	0.003	0.99	0.22	0.13
Triglycerides	0.26	0.04	−0.31	0.20	0.32	0.03
Insulin	0.31	0.01	0.22	0.36	0.48	0.0006
Glucose	0.14	0.28	0.006	0.98	0.32	0.03
HbA1c	0.31	0.02	−0.22	0.39	0.42	0.009
HOMA‐IR	0.30	0.01	0.20	0.41	0.48	0.0007
Adiponectin	−0.02	0.89	0.22	0.37	−0.12	0.44
Leptin	0.24	0.06	0.14	0.56	−0.17	0.27

LDL: low‐density lipoprotein; HDL: high‐density lipoprotein; HOMA‐IR: homeostatic model of insulin resistance; HbA1c: glycated hemoglobin.

P‐values indicate statistically significant correlations (P < 0.05) in bold.